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Abstract Perilipin 5 (PLIN5/OXPAT) is a lipid droplet
(LD) coat protein mainly present in tissues with a high fat-
oxidative capacity, suggesting a role for PLIN5 in facilitat-
ing fatty acid oxidation. Here, we investigated the role of
PLIN5 in fat oxidation in skeletal muscle. In human skele-
tal muscle, we observed that PLIN5 (but not PLIN2) pro-
tein content correlated tightly with OXPHOS content and in
rat muscle PLIN5 content correlated with mitochondrial
respiration rates on a lipid-derived substrate. This prompted
us to examine PLIN5 protein expression in skeletal muscle
mitochondria by means of immunogold electron micros-
copy and Western blots in isolated mitochondria. These
data show that PLIN5, in contrast to PLIN2, not only local-
izes to LD but also to mitochondria, possibly facilitating
fatty acid oxidation. Unilateral overexpression of PLIN5 in
rat anterior tibialis muscle augmented myocellular fat stor-
age without increasing mitochondrial density as indicated
by the lack of change in protein content of Wve components
of the OXPHOS system. Mitochondria isolated from
PLIN5 overexpressing muscles did not possess increased
fatty acid respiration. Interestingly though, 14C-palmitate oxi-
dation assays in muscle homogenates from PLIN5 over-
expressing muscles revealed a 44.8% (P = 0.05) increase in
complete fatty acid oxidation. Thus, in mitochondrial isola-
tions devoid of LD, PLIN5 does not augment fat oxidation,
while in homogenates containing PLIN5-coated LD, fat oxi-
dation is higher upon PLIN5 overexpression. The presence of
PLIN5 in mitochondria helps to understand why PLIN5, in
contrast to PLIN2, is of speciWc importance in fat oxidative
tissues. Our data suggests involvement of PLIN5 in directing
fatty acids from the LD to mitochondrial fatty acid oxidation.
Keywords PLIN5 · OXPAT · Perilipin · Lipid droplet · 
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Introduction
Perilipin 5 (aliases include OXPAT, lipid storage droplet
protein 5, myocardial lipid droplet protein and PAT-1) is a
lipid droplet (LD) coat protein that belongs to the perilipin
family of proteins. Although the tissue distribution of this
protein family diVers considerably between members, all
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perilipin proteins are involved in accumulation and metabo-
lism of lipids in LDs (Bickel et al. 2009; Brasaemle 2007).
Perilipin 5 (PLIN5) expression is highest in tissues with a
high fat-oxidative capacity, such as heart, oxidative (type I)
skeletal muscles and brown adipose tissue (Yamaguchi
et al.  2006; Wolins et al. 2006; Dalen et al. 2007).
Recently, we showed that in rat and human skeletal muscle,
PLIN5 protein content paralleled the LD content, with most
abundant expression in muscle Wbres that have highest fat
content (type 1 Wbres in humans, type 2a in rodents) (Minn-
aard et al. 2009).
PLIN5 has been found covering the lipid droplet and to
be present in the cytosol (Wolins et al. 2006; Yamaguchi
et al. 2006). PLIN5 overexpression in vitro in OP-9 and
COS-7 cells increased cellular triglyceride storage in paral-
lel with increases in fatty acid (FA) oxidation and induction
of gene expression of mitochondrial enzymes involved in
oxidative metabolism (Wolins et al. 2006). These results
suggest involvement of PLIN5 in triglyceride storage as
well as oxidative degradation of FAs released from the
droplet, and suggest involvement of PLIN5 in lipid turn-
over. Recently, it has been shown that PLIN5 indeed has
the potential to modulate the interaction of the major
triacylglycerol lipase ATGL with the LD as well as with its
co-factor CGI-58 (Lass et al. 2006) in a well orchestrated
manner to modulate LD lipolysis (Granneman et al. 2009,
2011; Wang et al. 2011a).
To maintain cellular concentrations of cytotoxic FAs
low, eVective shuttling of FAs towards mitochondrial oxi-
dation should be facilitated. In oxidative tissues this is in
part facilitated by the close vicinity, and sometimes even
physical interaction of LD with mitochondria. Functional
interactions between LDs and mitochondria have long been
reported (Blanchette-Mackie et al. 1995; Cohen et al. 2004;
Hoppeler  1999; Hoppeler et al. 1973), and evidence is
emerging that mitochondria are not only actively control-
ling FA levels in their vicinity by directing FAs towards
-oxidation, but the presence of the enzymatic machinery
to re-esterify FA in mitochondria indicates that mitochon-
dria may also have the option to redirect the fatty acids
towards triacylglycerol synthesis in LD. Likewise, isoforms
of acyl CoA:diacylglycerol acyltransferase (DGAT) (Stone
et al. 2009), glycerol 3-phosphate acyl transferases (GPAT)
(Hammond et al. 2002; Lewin et al. 2004) and long-chain
acyl-CoA synthetases (Ellis et al. 2010) have been identi-
Wed in mitochondria. Orchestrated interaction of processes
at the LD and the mitochondria is hence of pivotal impor-
tance in tissues like cardiac and skeletal muscle and brown
adipose tissue where large Xuctuations in fatty acid oxida-
tion are prominent. These tissues also typically express
PLIN5 as a LD coat protein.
Imaging the LDs and PLIN5 by immunoXuorescence
revealed that the majority of PLIN5 is localised to the
lipid droplet but also that—mainly in fat oxidative type I
muscle Wbres—PLIN5 could be readily detected in a staining
pattern similar to recognised mitochondrial proteins
(Minnaard et al. 2009). This staining pattern, along with the
high expression of PLIN5 in tissues with high FA oxidation
capacity (Dalen et al. 2007; Wolins et al. 2006; Yamaguchi
et al. 2006) and the observation that overexpressing PLIN5
increased both palmitate oxidation and the expression of
genes encoding mitochondrial proteins (Wolins et al. 2006)
hints towards involvement of PLIN5 in mitochondrial fat
oxidation. Likewise, it has recently been suggested that
PLIN5 at the LD surface may recruit LD to the mitochon-
dria (Wang and Sztalryd 2011).
We here show that PLIN5 is present within the mito-
chondria in cardiac and skeletal muscle. PLIN5 overexpres-
sion in skeletal muscle indicates that lipid droplets and
mitochondria need interaction before PLIN5 possesses its
facilitating role to augment mitochondrial fat oxidation.
Materials and methods
PLIN5 antibody
The PLIN5 antibody used in this study is directed against
amino acids 451–463 of the C-terminus and was derived
from Progen (#GP31; guinea pig polyclonal; Progen, Hei-
delberg, Germany). This antibody, as well as other avail-
able antibodies against PLIN5, was tested in pilot
experiments (Western blots and immunogold labelling for
electron microscopy) in a variety of cells and tissues known
to vary in endogenous PLIN5 protein expression (HEK and
C2C12 cells, white adipose tissue, cardiac muscle, glyco-
lytic skeletal muscle (EDL), oxidative skeletal muscle
(soleus), liver and testis). Thus, PLIN5 expression was
highest in oxidative tissues (heart and oxidative skeletal
muscle). The antibody used in this study showed the
expected tissue distribution, a double band of the expected
size, and a low background and speciWc PLIN5 labelling on
the transmission electron microscopy pictures. Negative
controls using non-immune serum did not show any bands
in Westerns nor did it result in immunogold or immunoXu-
orescence staining.
Cell culture and treatments
HEK293 cells (LGC standards, Teddington, Middlesex,
United Kingdom) were maintained in DMEM (GlutaMAX
low glucose DMEM, Invitrogen, Breda, The Netherlands)
containing antibiotics (50 U/ml penicillin and 50 g/ml
streptomycin; Gibco-Invitrogen, Rockville, USA) supple-
mented with 10% FCS. Cells were transfected with Plin5
plasmid construct (pcDNA3.1-CMV (2 g per well of aHistochem Cell Biol (2012) 137:205–216 207
123
12-well plate) using 10 L/ml Lipofectamine 2,000 as
transfection reagent (Invitrogen, Breda, The Netherlands).
Cells were harvested 24 h posttransfection.
Human study
Eleven healthy, lean, male volunteers without a family his-
tory of diabetes or any other endocrine disorder participated
in this study. The mean age of the subjects was
23.6 § 1.0 years; mean BMI was 22.6 § 0.5 kg/m2. Sub-
jects were fed in energy balance for 60 h (50–35–15% of
energy as carbohydrates, fat and protein, respectively).
After 60 h, a muscle biopsy of the vastus lateralis was
taken using the Bergstrom technique (Bergstrom 1975).
Muscle samples were immediately frozen in melting iso-
pentane and stored at 80°C until assayed. The study proto-
col was reviewed and approved by the Medical Ethical
Committee of Maastricht University Medical Centre and all
subjects gave their written informed consent before partici-
pating in the study.
ZDF rat study design
Twenty-six male, ZDF rats (ZDF/Gmi, fa/fa) were pur-
chased from Charles River (Chatillon-sur-Chalaronne,
France). The rats arrived at the age of 5 or 11 weeks and
were housed in pairs with ad libitum access to tap water
and chow. At 6, 12, and 19 weeks of age (n =8 ,   n =8 ,  a n d
n = 10, respectively), rats were killed by cervical disloca-
tion, and hind leg muscles were rapidly dissected. The tib-
ialis anterior muscle was processed for mitochondrial
isolation (Lenaers et al. 2010) and soleus and EDL mus-
cles were processed for electron microscopy or rapidly
frozen in melting isopentane (Fluka, Zwijndrecht, The
Netherlands), and stored at ¡80°C. All experiments were
approved by the The Animal Care and Use Committee of
Maastricht University (approval number 2005-058) and
the study complied with the principles of laboratory ani-
mal care.
Electroporation study design
A total of eighteen 8-week-old male Wistar rats were pur-
chased from Charles River (Wilmington, Massachusetts,
USA). Rats were housed individually on a 12:12 h light–
dark cycle (light from 7:00 am to 7:00 pm), at room tem-
perature (21–22°C) with ad libitum access to tap water.
Rats were fed a high fat diet (45% energy from fat,
D01060502, Research Diets, New Brunswick, NJ, USA)
for the duration of the 3-week intervention. The Animal
Care and Use Committee of Maastricht University
approved the experiments (approval number 2010-036) and
the study complied with the principles of laboratory animal
care. During the experiments, all eVorts were made to mini-
mise suVering of the animals.
Electroporation
Two weeks after the start of the diet, overexpression of
Plin5 in either the right or left tibialis anterior (TA) muscle
of the rat was accomplished by an in vivo DNA electro-
transfer technique to obtain overexpression of mouse perilipin
5 in one leg; the contralateral TA served as a sham-electro-
porated internal control. Plin5 was electroporated randomly
in the left or the right TA. DNA electroporation was per-
formed under isoXurane anaesthesia. TA muscles were
transcutaneously injected with either 150 g (2 g/l)
pcDNA3.1-CMV-Plin5 or pcDNA3.1-empty vector in
0.9% sterile NaCl. Within 15 s after the last injection 5
electric pulses were applied by two stainless steel plate
electrodes placed at the ventral and dorsal side of the leg.
One high voltage pulse of 800 V/cm and four low voltage
pulses of 80 V/cm at 1 Hz were generated by an ECM 830
electroporator (BTX, San Diego, CA, USA) as described
previously (Bruce et al. 2007, 2009). Rats were sacriWced
8 days postelectroporation. TA muscles were excised and
processed for mitochondrial isolations and electron micros-
copy. The remainder of the TA was rapidly frozen in melt-
ing isopentane for histology and protein isolations.
Mitochondrial isolations
After excision, the right and left TA muscles were placed
into ice-cold medium containing 100 mM sucrose, 100 Mm
KCl, 50 mM Tris–HCl, 1 mM KH2PO4, 0.1 mM EGTA,
and 0.2% (wt/vol) FA-free bovine serum albumin (pH 7.4).
The TA was immediately processed for mitochondrial iso-
lation, essentially according to Tonkonogi and Sahlin
(1997). The protein concentration in the mitochondrial pel-
let was measured using Xuorescamine (Fluram; Fluka,
Zwijndrecht, the Netherlands) with bovine serum albumin
as a standard (Udenfriend et al. 1972). Freshly isolated
mitochondria were used immediately for mitochondrial res-
pirometry. Remaining mitochondria were stored at ¡80°C
for further analysis.
High-resolution respirometry in isolated mitochondria
Mitochondrial oxygen consumption was measured essen-
tially according to Hoeks et al. (2008) at 37°C using a two-
chamber oxygraph (OROBOROS Instruments, Innsbruck,
Austria) and expressed as pmol O2/mg mitochondrial pro-
tein per second. Mitochondria were characterised using a
carbohydrate-derived substrate (5 mM pyruvate) and a
FA-derived substrate (50 M palmitoyl-CoA plus 2 mM
carnitine). For this purpose, mitochondria (0.1 mg for pyruvate208 Histochem Cell Biol (2012) 137:205–216
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and 0.2 mg for palmitoyl-CoA plus carnitine) were incubated
in a medium consisting of 100 mM sucrose, 20 mM K+-Tes
(pH 7.2), 50 mM KCl, 2 mM MgCl2,  1m M  E D T A ,  4m M
KH2PO4, 3 mM malate and 0.1% of FA-free BSA. Maximal
coupled (state 3) respiration was initiated by addition of
450 M of adenosine diphosphate (ADP). State 4o respiration,
reXecting proton leak, was measured as the residual respiration
following addition of 1 g/ml oligomycin (an F1-F0 ATPase
inhibitor). Maximal oxygen Xux rates (state uncoupled, state
U) were obtained by titration of the chemical uncoupler car-
bonyl cyanide p-triXuoromethoxyphenylhydrazone (FCCP).
Addition of excess cytochrome C to the chamber in the pres-
ence of pyruvate and ADP did not increase respiration (data
not shown); indicating that during isolation outer mitochon-
drial membrane integrity was retained.
14C-palmitate oxidation assay
Ex vivo fat oxidation was measured as described (Frisard
et al. 2010). BrieXy, muscle was homogenised in a buVer
(pH 7.4) containing 250 mM sucrose, 10 mM Tris–HCl,
2 mM ATP and 1 mM EDTA (Sigma, St. Louis, USA).
Subsequently, muscle homogenates were incubated for 2 h
with [1-14C]-labelled palmitate (1 Ci/ml, Perkin Elmer,
Boston, USA) and 200 M non-labelled (cold) palmitate in
reaction media containing L-carnitine, ATP and coenzyme
A (all from Sigma, St. Louis, USA) at 37°C. Palmitate was
coupled to FA-free BSA in a molar ratio of 5:1. After incu-
bation, reactions were terminated by adding 40 l of 70%
perchloric acid, and the CO2 produced during the incuba-
tion was trapped in 200 l of 1 N sodium hydroxide that
had been added to adjacent wells (Kim et al. 2002). The
acidiWed medium was stored at 4°C overnight, and then
acid soluble metabolites (ASMs) were assayed in superna-
tants of the acid precipitate. Radioactivity of CO2 and
ASMs was determined by liquid scintillation counting by
use of 5 ml of Hionic Fluor (Perkin Elmer, Boston, USA).
Data were normalised to protein content.
Electron microscopy procedures
Ultrastructural morphology and PLIN5 localization were
examined using transmission electron microscopy. For
determinations of ultrastructural morphology, muscle tissue
sections were Wxed in 2.5% glutaraldehyde in 0.1 M phos-
phate buVer (pH 7.4). PostWxation was performed in 1%
osmium tetroxide in 0.1 M cacodylate buVer (pH 7.4) sup-
plemented with 1.5% potassium ferrocyanide. The samples
were then dehydrated and embedded in epon. Ultrathin
sections were examined using a Philips CM100 electron
microscope.
For determinations of subcellular localization of PLIN5,
soleus, extensor digitorum longus (EDL) and heart muscle
tissues 14-week old ZDF rats (ZDF/Gmi, fa/fa) and tibialis
anterior muscle tissues from electroporated Wistar rats
were cut into pieces with a maximum size of 1 mm3, Wxed
for 1 h at room temperature in a mixture of 2% formalde-
hyde and 0.2% glutaraldehyde in 0.1 M phosphate buVer
(pH 7.4), and stored in 1% formaldehyde in 0.1 M phos-
phate buVer (pH 7.4). Tissue pieces were immersed in a
2.3 M sucrose solution, frozen in liquid nitrogen and ultra-
thin cryo-sections were cut under liquid nitrogen, sections
were transferred from the knife edge to a formvar and car-
bon-coated grid in 2.3 M sucrose/1.8% methylcellulose
(1:1), as described by Tokuyasu (1973,1980,1986) Sections
were immunogold labelled as described by Tokuyasu
(1986) using a PLIN5 antibody (#GP31; Guinea pig poly-
clonal; Progen Biotechnik, Heidelberg, Germany) in a
1:100 dilution and protein A-gold (20 nm particles) (Slot
and Geuze 1981). Guinea pig normal serum (Santa Cruz
Biotechnology, Tebu-bio, Heerhugowaard, The Nether-
lands) was used as a negative control.
Oil-red-O stainings and immunoXuorescence
Neutral lipids, mitochondria and PLIN5 in muscle sections
were stained with a modiWed Oil-red-O staining for Xuores-
cence microscopy as previously described (Koopman et al.
2001) using antibodies against PLIN5 (#GP31; Progen Bio-
technik, Heidelberg, Germany), laminin (L-9,393; Sigma,
St. Louis, USA), and OXPHOS (MS601; MitoSciences,
Eugene, OR, USA) and the appropriate secondary Alexa-
Xuor conjugated antibodies (Invitrogen, Groningen, The
Netherlands). Fluorescent images of Alexa-350 (laminin),
Alexa-488 (PLIN5), Alexa-647 (OXPHOS), and Oil-red-O
(visible in the red-594-channel) were acquired using an
imaging system consisting of an IX81 inverted microscope
(Olympus, Hamburg, Germany), an X-cite Xuorescent light
source (Lumen Dynamics group, Mississauga, Ontario,
Canada), F-view II CCD camera (OSIS, Münster,
Germany) and the Cell^F imaging software (OSIS). Fluo-
rescent photomicrographs were made from Z-stacks con-
sisting of 30-40 images with a distance of 0.28 m using
the maximum intensity projection method in the ImageJ
software (Rasband, W.S., ImageJ, U. S. National Institutes
of Health, Bethesda, Maryland, USA, http://rsb.info.
nih.gov/ij/, 1997–2009).
Western blots
Western blots were performed in protein lysates from
whole muscle homogenates or mitochondrial fractions.
Muscle samples and mitochondrial fractions were homoge-
nised in ice-cold PBS containing 1% Nonidet-P40, 0.5%
sodium dodecyl sulphate, 0.1 mM phenylmethylsulfonyl
Xuoride, complete inhibitor (Roche, Almere, The Netherlands)Histochem Cell Biol (2012) 137:205–216 209
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and processed for standard SDS-PAGE and Western blot-
ting. Protein concentration was determined and equal
amounts of protein were loaded per lane. The nitrocellulose
membranes were incubated with antibodies against PLIN5
(GP31; Progen Biotechnik, Heidelberg, Germany), PLIN2
(GP40; Progen Biotechnik, Heidelberg, Germany),
OXPHOS (MS601; MitoSciences, Eugene, OR, USA),
PGC1 (516,557; Calbiochem; VWR International BV,
Amsterdam, The Netherlands), VDAC (SC-8,828; Santa
Cruz Biotechnology, Tebu-bio, Heerhugowaard, The Neth-
erlands), and SR-actin (A-2,172; Sigma, St. Louis, USA).
Blots incubated with PLIN5, PLIN2, OXPHOS, PGC1,
VDAC and sr-actin were probed with appropriate
IRDye800-conjugated or IRDye700-conjugated secondary
antibodies (Rockland, Tebu-bio, Heerhugowaard, The
Netherlands, and LICOR Biosciences, Westburg, Leusden,
The Netherlands), and bands at a molecular weight corre-
sponding to the control samples were quantiWed using the
Odyssey infrared imaging system (LICOR Biosciences,
Westburg, Leusden, The Netherlands).
Statistical analysis
Results are presented as mean § SE. DiVerences between
groups were evaluated with paired t tests. Outcomes were
considered statistically signiWcant when P < 0.05 (two-
tailed). Pearson’s correlation coeYcients were used to
describe the linear association between variables. All analy-
ses were performed using the Statistical Package for the
Social Sciences (SPSS 16.0, Nieuwegein, The Netherlands)
software for Mac 16.0.
Results
Skeletal muscle PLIN5 protein content correlates 
with oxidative capacity
In order to explore the role of PLIN5 in skeletal muscle, we
measured PLIN5 protein content in muscle biopsies of vas-
tus lateralis muscle of young healthy male subjects. PLIN5
protein content correlated strongly with the protein content
of structural components of the individual complexes of the
electron transport chain; OXPHOS complexes I (r =0 . 7 2 1 ,
P = 0.012), III (r = 0.810,  P = 0.003), IV (r =0 . 7 0 4 ,
P = 0.016) and V (r = 0.606, P = 0.048) but not with protein
content of VDAC, an outer mitochondrial membrane pro-
tein without a recognised role in (fat) oxidation (r = 0.148,
P =0 . 6 6 4 )  ( n =1 1 )  ( T a b l e1). These observations indi-
rectly suggest a role of PLIN5 in mitochondrial fat oxida-
tive metabolism. This led us to investigate the relationship
between PLIN5 protein content in whole muscle homoge-
nates with respiration rates of isolated muscle mitochondria
on a fat-derived substrate (palmitoyl-CoA). Thus, we ana-
lysed correlations of skeletal muscle PLIN5 protein expres-
sion with mitochondrial function in a model of progressive
myocellular fat deposition, the maturing Zucker diabetic fatty
(ZDF) rats (fa/fa). In this model, PLIN5 protein content tracks
with intramyocellular lipid content (Minnaard et al. 2009).
We examined the correlation between PLIN5 content in
whole muscle homogenates and intrinsic mitochondrial func-
tion in mitochondria isolated from these muscles by classical
mitochondrial respirometry using palmitoyl-CoA as a FA-
derived substrate. In these rats, PLIN5 protein content, but
importantly not PLIN2 protein content, positively correlated
with ADP-driven state 3 respiration (r = 0.713, P < 0.001) as
well as respiration under maximal FCCP-mediated uncoupled
conditions (state U, r = 0.663,  P = 0.001) (Table 2). These
observations may indicate that in muscles in which PLIN5
protein content scales with LD content, PLIN5 is involved in
facilitating increased mitochondrial fat oxidation.
Perilipin 5 localizes to lipid droplets as well as to mito-
chondria in cardiac and skeletal muscle. The strong correla-
tion of PLIN5 protein content with OXPHOS complexes
and mitochondrial respiration on a FA-derived substrate led
us to examine whether PLIN5, next to its recognised locali-
sation to LD, is also present in mitochondria. Thus, we
Table 1 Correlation of PLIN5 
protein expression with 
OXPHOS complexes in human 
vastus lateralis muscle
VDAC OXPHOS I OXPHOS II OXPHOS III OXPHOS IV OXPHOS V
Pearson correlation ¡0.148 0.721* 0.455 0.810* 0.704* 0.606*
P 0.664 0.012 0.159 0.003 0.016 0.048
Table 2 Correlation of PLIN5 protein expression with respiration of
mitochondria isolated from skeletal muscle of fatty ZDF rats
Palmitoyl-CoA
State 3 State U
PLIN5
Pearson correlation 0.713* 0.663*
P <0.001 0.001
n 23 23
PLIN2
Pearson correlation 0.343 0.182
P 0.1 0.396
n 24 24210 Histochem Cell Biol (2012) 137:205–216
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measured PLIN5 protein content in total muscle protein
lysates as well as in mitochondrial fractions from rat skele-
tal muscle (Fig. 1a). A double band representing PLIN5
was observed in whole muscle lysates and more strikingly
also in isolated mitochondria. To exclude the ability that
the PLIN5 signal detected in the mitochondria originated
from contamination of the mitochondrial fraction with ER
or LD derived membrane fractions we examined protein
expression of ADRP/PLIN2 in our mitochondrial fractions
(Fig. 1b). The absence of an ADRP/PLIN2 band indicates
that the mitochondrial fractions used were devoid of ER or
LD membrane structures, substantiating our notion that
PLIN5 indeed localizes to mitochondria.
We further substantiated mitochondrial localisation of
PLIN5 using immunogold electron microscopy, the gold
standard methodology for subcellular localisation studies of
single proteins. In all muscles examined (soleus, EDL and
cardiac muscle) PLIN5 was present on the LDs, at the inter-
face of LDs with mitochondria, as well as in the mitochon-
dria (Fig. 1c, d), whereas other structures were almost
completely devoid of gold particles. Negative controls by
omission of the primary antibody or by using non-immune
serum did not show any immunogold staining. Immuno-
gold staining using the ADRP/PLIN2 antibody only
revealed staining associated with LD (data not shown).
PLIN5 overexpression in rat tibialis anterior muscle
To examine the eVect of overexpression of PLIN5 on its sub-
cellular localisation, a CMV-driven full-length PLIN5 con-
struct was used for unilateral overexpression of PLIN5 in rat
tibialis anterior muscle by gene electroporation using the
contralateral empty vector-electroporated leg as an internal
control. Upon transfection in HEK cells the construct used
resulted in the anticipated double band on the Western, repre-
senting two PLIN5 isoforms (Fig. 2a). In rat tibialis anterior
muscle, PLIN5 overexpression doubled PLIN5 protein con-
tent in whole muscle homogenates (P = 0.0006,  n =1 4 ,
paired  t test) (Fig. 2b). Consistent with results obtained in
vitro (Dalen et al. 2007; Wolins et al. 2006), PLIN5
overexpression profoundly augmented intramyocellular lipid
storage in the transfected muscle (Fig. 2c). Immunohisto-
chemistry revealed that PLIN5 was present on LDs and
showed punctuate mitochondrial localisation. Double immu-
noXuorescence using an antibody cocktail against structural
components of all 5 OXPHOS complexes conWrmed co-
localisation of PLIN5 with mitochondria (Fig. 2d). Ultra-
structural analysis by electron microscopy conWrmed the
light microscopy based observation of augmented lipid stor-
age upon PLIN5 overexpression and clearly showed
increased LD size (Fig. 3). In addition, almost all LD appear
Fig. 1 Perilipin 5 protein expression in whole muscle homogenates,
isolated mitochondria and muscle sections. a Western blotting of per-
ilipin 5 in whole skeletal muscle lysates from heart muscle, extensor
digitorum longus (EDL) and tibialis anterior muscles and mitochondria
isolated from tibialis anterior muscle. b Western blots incubated with
the PLIN2 antibody did not show any bands in isolated mitochondria,
indicating that the mitochondrial fraction was devoid of lipid droplets
and was not contaminated with fragments of the ER. HEK cells trans-
fected with PLIN2 plasmid were used as positive control. c PLIN5 im-
munogold labelling in rat soleus muscle. PLIN5 coats the lipid droplets
and is present at mitochondria but not at myoWbrils. d PLIN5 immuno-
gold labelling in rat left ventricle showing mitochondrial localization
of PLIN5. LD lipid droplet, M mitochondrionHistochem Cell Biol (2012) 137:205–216 211
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to interact tightly with mitochondria in the PLIN5-over-
expressing muscle and sometimes even appear to envelop the
lipid droplets (Fig. 3). Immunogold labelling of PLIN5 in
electroporated muscle conWrmed the localization of PLIN5 in
mitochondria, on LDs and on the LD-mitochondrial interface
(Fig. 4).
PLIN5 overexpression does not aVect mitochondrial 
density
To examine the putative eVect of PLIN5 overexpression on
mitochondrial density, we measured in whole muscle
homogenates the protein content of PGC1 (Fig. 5a),
VDAC (Fig. 5b) and 5 distinct structural components of
subunits of the individual OXPHOS complexes (complex I
subunit NDUFB8, complex II subunit 30 kDa, complex III
subunit Core 2, complex IV subunit I and complex V ATP
synthase subunit alpha (Fig. 5c). Although we observed a
non-signiWcant (P = 0.14) increase in PGC1, a key co-
activator for mitochondrial biogenesis, protein content of
VDAC and OXPHOS complexes remained unaltered, indi-
cating that 8 days after overexpressing PLIN5 mitochon-
drial density was not aVected.
PLIN5 overexpression does not improve respiration 
of isolated mitochondria
Mitochondrial respirometry assays in the mitochondria iso-
lated from PLIN5 overexpressing muscles relative to mus-
cles isolated from empty vector-electroporated muscles did
Fig. 2 PLIN5 overexpression (gene electroporation) in rat muscle
using an empty vector as internal control. a SpeciWcity of the PLIN5
antibody (Progen). A full-length PLIN5 vector was transfected in cells
without endogenous PLIN5 expression (HEK cells), this resulted in
ectopic expression of PLIN5. b PLIN5 protein content in protein
lysates from electroporated tibialis anterior muscle (n =1 6 ) .  Error
bars represent SEM, *P < 0.01. The samples were derived from the
same experiment and were simultaneously processed in random order
on two gels/blots. EV: empty vector. c Shows the eVect of PLIN5
overexpression on lipid storage (upper right hand panel) and PLIN5
content (lower right hand panel) compared to the empty vector control
(upper and lower left hand panels). LDs are stained in red), PLIN5 in
green and cell membranes in blue. Bars represent 100 m. d Overlay
of PLIN5 and mitochondrial proteins upon PLIN5 overexpression.
PLIN5 overexpression increases LD (in red) and PLIN5 (in green)
content (upper right hand and middle left hand panel, respectively).
Mitochondria are shown in magenta (middle left hand panel). The low-
er left hand panel shows LD decorated with PLIN5 while the lower
right hand panel shows PLIN5 interaction with mitochondria. The bar
represents 20 m. Representative image are shown212 Histochem Cell Biol (2012) 137:205–216
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not reveal signiWcant diVerences in respiration, neither on
pyruvate (empty vector vs. PLIN5 15.98 § 1.17 vs.
15.48 § 1.18 state 3/state 2, P = 0.83; 22.53 § 0.88 vs.
22.29 § 1.44 state U/state 2, P = 0.68), nor on palmitoyl-
CoA (empty vector vs. PLIN5 6.76 § 0.38 vs. 7.36 § 0.30
state 3/state 2, P = 0.23; 8.56 § 0.63 vs. 9.14 § 0.49 state
U/state 2, P =0 . 3 7 )  ( F i g .6a, b). Thus, in a system in which
PLIN5-coated LDs are dissociated from the mitochondria,
PLIN5 overexpression does not augment mitochondrial
(fat) oxidative capacity.
PLIN5 overexpression improved 14C-palmitate oxidation
Given the intimate association of LDs with mitochondria
we performed complementary measurements of fat oxida-
tion using 14C-palmitate in whole muscle homogenates
when LDs and mitochondria were not dissociated. Total
14C-palmitate oxidation was not changed (empty vector
0.71 § 0.06 nmol/2 h/mg protein, PLIN5 0.71 § 0.03
nmol/2 h/mg protein, P =0 . 9 9 )  ( F i g .6c). However, oxida-
tion of 14C-palmitate to 14CO2 increased by 44.8% (empty
vector 0.05 § 0.008, PLIN5 0.07 § 0.012  14CO2/total
14C-palmitate oxidation, P =0 . 0 5 )  ( F i g .6d). The respira-
tion data in isolated mitochondria and in muscle homoge-
nates jointly indicate that overexpression of PLIN5 does
not augment mitochondrial fat oxidative capacity per se but
rather creates a situation in which shuttling of FAs towards
mitochondria becomes more eYcient, thereby protecting
mitochondria against the deleterious eVects of lipid overXow.
Discussion
PLIN5 was recently identiWed as a member of the perilipin
family of lipid droplet coating proteins and was considered
to be an exchangeable LD coat protein; unlike perilipins 1
and 2, PLIN5 is not exclusively found in the LD coat but
also cytosolically (Dalen et al. 2007; Wolins et al. 2006;
Yamaguchi et al. 2006). Using a variety of validated tech-
niques, however, we here show that PLIN5 in muscle is
found at the LDs as well as in mitochondria, this in contrast
to PLIN2, the other major LD coat protein found in muscle.
PLIN5 positive mitochondria were detected in oxidative
(soleus), glycolytic (EDL), and mixed (TA) muscles as well
Fig. 3 PLIN5 overexpression results in large LDs. Left hand panels
a and  c show empty vector control data, right hand panels  b and
d show PLIN5 overexpression data. Note the apparent larger LD size
upon PLIN5 overexpression. Bar represents 10 m in the upper panel
and 2 m in the lower panels
Fig. 4 PLIN5 labelling in mitochondria and on the lipid droplets.
Immunogold staining of PLIN5 in tibialis anterior muscle of empty vec-
tor (control) (a) or PLIN5-electroporated muscle (b). PLIN5
overexpression b, c and d resulted in larger lipid droplets and intimate
interaction of lipid droplets with mitochondria at PLIN5 positive sites
(see arrowheads in c and d). Bars represent 1 m. e Intramitochondrial
PLIN5 labelling. Bar represents 0.5 mHistochem Cell Biol (2012) 137:205–216 213
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as in cardiac muscle. Both subsarcolemmal mitochondria
and intramyoWbrillar mitochondria contained PLIN5. Gene
electroporation mediated overexpression of PLIN5 doubled
PLIN5 protein content and resulted in more numerous and
apparently larger LDs in intimate interaction with mito-
chondria. Functional assays revealed no direct involvement
of PLIN5 in mitochondrial respiration, as respiration in iso-
lated mitochondria was not aVected by PLIN5 overexpres-
sion. Interestingly though, fatty acid oxidation rates were
higher in whole muscle homogenates of PLIN5 over-
expressing muscles, suggesting a facilitating role of PLIN5
in augmenting fat oxidation situations when LDs are physi-
cally interconnected to the mitochondrial reticulum, possi-
bly by shuttling or chaperoning of LD-derived FAs towards
mitochondria for oxidation.
Recent reports have shown that PLIN5 localised to LDs
in tissues rich in mitochondria (Dalen et al. 2007; Wolins
et al.  2006; Yamaguchi et al. 2006), that overexpressing
PLIN5 in OP-9 and COS-7 cells promoted fat oxidation
(Wolins et al. 2006) and that the proteome of LDs con-
tained multiple mitochondrial proteins (Brasaemle et al.
2004). In addition, PLIN5 interaction with ATGL on LDs
and on undeWned intracellular structures lacking neutral lip-
ids (Granneman et al. 2011) has been reported. This has led
us to investigate the possibility that PLIN5 also localizes to
mitochondria.
Thus, we observed that PLIN5 protein content in vastus
lateralis muscle of healthy young male subjects correlated
positively and tightly with structural components of all Wve
complexes of the electron transport chain, but not with
mitochondrial proteins without a recognised role in fat oxi-
dation. The lack of associations of PLIN5 with VDAC, a
mitochondrial protein not involved in (fat) oxidation, nar-
rows the interpretation of previous observations of PLIN5
being abundant in mitochondria rich tissues (Dalen et al.
2007; Wolins et al. 2006; Yamaguchi et al. 2006) and may
hint towards a more direct involvement of PLIN5 in mito-
chondrial fat oxidation. Hence, we studied ADP-driven res-
piration rates on palmitoyl-CoA in mitochondria isolated
from tibialis anterior muscles of ZDF rats with a range in
myocellular fat content. We previously observed that mus-
cles of these rats have increased PLIN5 and PLIN2 protein
content which tracked with intramyocellular fat content
(Minnaard et al. 2009). Fascinatingly, coupled respiration
and maximal respiration on palmitoyl-CoA correlated
tightly with muscle PLIN5 content but interestingly not
with PLIN2 content. Thus, only PLIN5 paralleled changes
in mitochondrial fat oxidative capacity. Upon Western blot-
ting isolated mitochondria with a speciWc PLIN5 antibody,
we were able to unmask PLIN5 as a mitochondrial protein.
The mitochondrial isolation protocol used results in a very
clean mitochondrial homogenate without contamination of
other membrane structures of remnants of LD membranes.
This was substantiated by the observation that the mito-
chondrial isolation was negative for PLIN2, while showing
clear PLIN5 bands in mitochondria isolated from a variety
Fig. 5 Abundance of mitochon-
drial proteins upon PLIN5 over-
expression. Western blots were 
performed for expression of 
PGC1 (a), VDAC (b)a n d   Wve 
distinct structural components of 
the OXPHOS complexes (c)i n  
lysates from whole muscle 
homogenates (n = 14). Error 
bars represent SEM, *P <0 . 0 1 .  
The samples were derived from 
the same experiment and were 
simultaneously processed in 
random order
A
C
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of skeletal and cardiac muscles. To further substantiate
these Wndings we performed double immunoXuorescence
microscopy with PLIN5 along with an antibody against
structural components of the electron transport chain in rat
tibialis anterior muscles. Confocal analysis of tissue sec-
tions indeed localised PLIN5 to the LD, but also to the
mitochondria. For a more detailed conWrmation of PLIN5
being expressed in mitochondria we applied post-embed-
ding immunogold electron microscopy, the gold standard
for high-resolution subcellular localisation studies of pro-
teins (Zuber et al. 2005). Thus, we identiWed PLIN5 to the
LD membrane as well as in mitochondria in sections from
rat glycolytic (EDL), oxidative (soleus) and cardiac muscle.
PLIN5 was consistently present in subsarcolemmal as well
as in intermyoWbrillar mitochondria of all muscle types
examined. Again, no such observations were made for
PLIN2, the other major LD coat protein in muscle. Except
for LDs, other organelles and myoWbrillar structures were
almost devoid of any PLIN5 signal.
Having identiWed PLIN5 in mitochondria we set out to
investigate the eVect of PLIN5 overexpression on PLIN5
subcellular distribution and myocellular ultrastructure. We
deliberately choose unilateral gene electroporation as the in
vivo approach to overexpress PLIN5 in the tibialis anterior
muscle of a rat. Thus, we were able to avoid lifelong adap-
tive responses while creating the ability to use the contralat-
eral leg as an internal control. This resulted in a two-fold
overexpression of PLIN5. ImmunoXuorescence microscopy
and immunogold electron microscopy in tibialis anterior
samples of the control and the overexpressing muscle con-
Wrmed speciWc localisation of PLIN5 to mitochondria and
lipid droplets. No apparent changes in the subcellular distri-
bution of PLIN5 were observed, i.e., subsarcolemmal and
intermyoWbrillar mitochondria pools both remained PLIN5
positive and qualitative examination of electron microscopi-
cal images did not indicate selective upregulation of PLIN5
at the LD site or at mitochondria. Using a variety of mito-
chondrial proteins we did not obverse indications of
increased mitochondrial density upon PLIN5 overexpres-
sion during the 8 day time span of PLIN5 overexpression.
Moreover, PLIN5 overexpression augmented intramyo-
cellular lipid storage and LD size, possibly reXecting the
involvement of PLIN5 in ATGL-mediated lipolysis
(Granneman et al. 2011; Wang et al. 2011a). The localiza-
tion of PLIN5 on the LDs and in mitochondria suggests a
role for PLIN5 in directing or binding fatty acids—or fatty
Fig. 6 EVects of PLIN5 overexpression on mitochondrial respiration
and FA oxidation. a and b State 3 (coupled) and state U (uncoupled)
respiration on palmitoyl-CoA (a) or pyruvate (b), values are standard-
ised to state 2 respiration (background respiration in the absence of
ADP) (n =9 ) .   c Total 14C-palmitate oxidation in muscle homogenates
(CO2 plus ASMs). d The ratio of CO2 production (complete oxidation)
to total FA oxidation (CO2 plus acid soluble metabolites) (n =7 ) .   Error
bars represent SEM, P values were derived from paired t testsHistochem Cell Biol (2012) 137:205–216 215
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acid derivatives—for mitochondrial oxidation. Measure-
ments of respiration in isolated mitochondria did not reveal
any diVerences between mitochondria derived from the
sham- and the PLIN5-electroporated muscle, which does
not support a direct role for PLIN5 in mitochondrial respi-
ration. Interestingly though, when examining 14C-palmitate
oxidation in muscle homogenates—when mitochondria are
not examined in isolation but in context of their native sub-
cellular milieu—we observed increased complete oxidation
of 14C-palmitate to CO2. This occurred in the absence of an
increase in accumulation of acid soluble metabolites, indi-
cating that the supply of fatty acids and/or the rate of -oxi-
dation were better matched with the capacity for
downstream FA oxidative metabolism. It should be noted
that, albeit unlikely, we could not exclude the possibility
that, during the isolation of mitochondria, the stronger
physical interaction between mitochondria and lipid drop-
lets upon PLIN5 overexpression resulted in a loss of mito-
chondria intimately connected to the large lipid droplets.
This could explain the discrepancy in the results of the
experiments in muscle homogenates and isolated mitochon-
dria. Nevertheless, the increase 14C-palmitate to CO2 points
towards a beneWcial eVect of PLIN5 overexpression on
mitochondrial fatty acid oxidation.
Thus, given the dual localization of PLIN5 to the LD and
to mitochondria, it is tempting to speculate that next to a role
for PLIN5 in releasing fatty acids from the LD by co-regulat-
ing lipolysis, PLIN5 is also involved in shuttling/chaperoning/
binding fatty acids or fatty acid derivatives from LD origin to
mitochondria for sake of oxidation. While this suggestion
clearly needs further experimental substantiation, it is well in
line with previous observations by others that overexpressing
PLIN5 augmented fat oxidation (Wolins et al. 2006). In the
process of Wnalising this manuscript, Wang et al. (Wang et al.
2011b) showed that PLIN5 is an important mediator of the
release of fatty acids for mitochondrial -oxidation in liver
cells. Upon PKA stimulation, PLIN5 increases LD hydrolysis
thus making fatty acids available for downstream mitochon-
drial metabolism (Wang et al. 2011b). Whether the same
holds true for muscle deserves further investigation.
Although our data clearly support mitochondrial localiza-
tion of PLIN5 it remains to be solved how PLIN5 gets into
mitochondria. We were unable to Wnd evidence for an N-ter-
minal mitochondrial targeting pre-sequence following tar-
geted database searches using PSORT (Horton et al. 2007)
and SignalP (Dyrløv Bendtsen et al. 2004). Although such a
pre-sequence is common for many mitochondrial proteins
(van der Laan et al. 2010), it should be noted that a variety of
other mitochondrial proteins do not contain such a pre-
sequence either (Dukanovic and Rapaport 2011). Rather, the
mitochondrial localization of these proteins is determined by
structural characteristics of the protein. It has been postulated
that protein localization to LDs is determined by basic and
hydrophobic domains, with remarkable similarities to the sig-
nals that target proteins to mitochondria (Ingelmo-Torres
et al. 2009). Interestingly, we did Wnd structural homology of
PLIN5 with the alpha and beta chains of the mitochondrial
protein ATP synthase (PropSearch) (Hobohm and Sander
1995), providing additional support for structural characteris-
tics in the PLIN5 sequence that could determine mitochon-
drial localization. Proteome analysis of the LD coat
interestingly revealed that the mitochondrial protein ATP
synthase was present in LD fractions of lipolytically stimu-
lated adipocytes (Brasaemle et al. 2004). Thus, PLIN5 would
not be the Wrst protein localised to mitochondria and lipid
droplets while lacking a mitochondrial targeting pre-
sequence. Moreover, recent work revealed that the last 20
amino acids of the C-terminal end of the protein were identi-
Wed to be essential for recruitment of mitochondria to the
lipid droplet surface (Wang et al. 2011b).
In conclusion, we provide evidence that PLIN5 is abun-
dantly expressed in subsarcolemmal and intermyoWbrillar
mitochondria of glycolytic, oxidative and cardiac muscle as
well as on the interface of mitochondria and lipid droplets.
PLIN5 overexpression augmented fat oxidation in muscle
homogenates containing both LDs and mitochondria but
not in isolated mitochondria. These Wndings unmask PLIN5
as a protein localised to LD and mitochondria with a puta-
tive role in channelling LD derived fatty acids towards
mitochondrial oxidation. Interaction of PLIN5 coated LD
with mitochondria appears more frequent and more inti-
mate upon skeletal muscle PLIN5 overexpression.
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